US Stock MarketDetailed Quotes

GDTC CytoMed Therapeutics

Watchlist
  • 2.255
  • 0.0000.00%
Close May 15 13:28 ET
26.02MMarket Cap-8477P/E (TTM)

CytoMed Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(FY)Dec 31, 2022
(FY)Dec 31, 2021
(FY)Dec 31, 2020
Total revenue
0
0
0
0
Operating revenue
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
106.99%3.84M
7.43%1.86M
37.57%1.73M
1.26M
Selling and administrative expenses
223.37%1.28M
36.32%397.11K
47.87%291.32K
--197.01K
-Selling and marketing expense
--33.31K
--0
-59.87%2.48K
--6.18K
-General and administrative expense
214.98%1.25M
37.49%397.11K
51.36%288.84K
--190.83K
Research and development costs
4.40%1.59M
39.62%1.52M
5.06%1.09M
--1.04M
Depreciation amortization depletion
-6.88%104.05K
10.38%111.75K
16.86%101.23K
--86.63K
-Depreciation and amortization
-6.88%104.05K
10.38%111.75K
16.86%101.23K
--86.63K
Other taxes
-5.45%6.66K
72.63%7.05K
17.17%4.08K
--3.48K
Other operating expenses
571.33%858.3K
-175.58%-182.1K
449.36%240.93K
---68.96K
Operating profit
-106.99%-3.84M
-7.43%-1.86M
-37.57%-1.73M
-1.26M
Net non-operating interest income expense
290.48%234.44K
-7.65%-123.08K
-8.35%-114.33K
-105.52K
Non-operating interest income
13,525.13%285.72K
-37.76%2.1K
--3.37K
--0
Non-operating interest expense
-59.03%51.28K
6.35%125.18K
11.54%117.7K
--105.52K
Other net income (expense)
54.43%-524.11K
-449.29%-1.15M
63.51%-209.39K
-573.86K
Gain on sale of security
-1,391.77%-394.16K
-178.68%-26.42K
-2,089.61%-9.48K
---433
Earnings from equity interest
7.00%-31.2K
84.22%-33.55K
---212.58K
--0
Special income (charges)
--0
--280
--0
--0
-Gain on sale of property,plant,equipment
--0
--280
--0
--0
Other non- operating income (expenses)
90.94%-98.75K
-8,709.51%-1.09M
102.21%12.67K
---573.42K
Income before tax
-32.04%-4.13M
-52.53%-3.13M
-6.01%-2.05M
-1.94M
Income tax
-60.18%653
1.64K
0
0
Net income
-31.99%-4.13M
-52.61%-3.13M
-6.01%-2.05M
-1.94M
Net income continuous Operations
-31.99%-4.13M
-52.61%-3.13M
-6.01%-2.05M
---1.94M
Minority interest income
-12.76%-274
3.95%-243
-36.02%-253
-186
Net income attributable to the parent company
-31.99%-4.13M
-52.62%-3.13M
-6.00%-2.05M
-1.94M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-31.99%-4.13M
-52.62%-3.13M
-6.00%-2.05M
-1.94M
Basic earnings per share
-36.26%-0.39
-52.62%-0.2862
-6.00%-0.1875
-0.1769
Diluted earnings per share
-36.26%-0.39
-52.62%-0.2862
-6.00%-0.1875
-0.1769
Dividend per share
Currency Unit
SGD
SGD
SGD
SGD
Audit Opinions
Unqualified Opinion
Unqualified Opinion
--
--
(FY)Dec 31, 2023(FY)Dec 31, 2022(FY)Dec 31, 2021(FY)Dec 31, 2020
Total revenue 0000
Operating revenue --0--0--0--0
Cost of revenue
Gross profit
Operating expense 106.99%3.84M7.43%1.86M37.57%1.73M1.26M
Selling and administrative expenses 223.37%1.28M36.32%397.11K47.87%291.32K--197.01K
-Selling and marketing expense --33.31K--0-59.87%2.48K--6.18K
-General and administrative expense 214.98%1.25M37.49%397.11K51.36%288.84K--190.83K
Research and development costs 4.40%1.59M39.62%1.52M5.06%1.09M--1.04M
Depreciation amortization depletion -6.88%104.05K10.38%111.75K16.86%101.23K--86.63K
-Depreciation and amortization -6.88%104.05K10.38%111.75K16.86%101.23K--86.63K
Other taxes -5.45%6.66K72.63%7.05K17.17%4.08K--3.48K
Other operating expenses 571.33%858.3K-175.58%-182.1K449.36%240.93K---68.96K
Operating profit -106.99%-3.84M-7.43%-1.86M-37.57%-1.73M-1.26M
Net non-operating interest income expense 290.48%234.44K-7.65%-123.08K-8.35%-114.33K-105.52K
Non-operating interest income 13,525.13%285.72K-37.76%2.1K--3.37K--0
Non-operating interest expense -59.03%51.28K6.35%125.18K11.54%117.7K--105.52K
Other net income (expense) 54.43%-524.11K-449.29%-1.15M63.51%-209.39K-573.86K
Gain on sale of security -1,391.77%-394.16K-178.68%-26.42K-2,089.61%-9.48K---433
Earnings from equity interest 7.00%-31.2K84.22%-33.55K---212.58K--0
Special income (charges) --0--280--0--0
-Gain on sale of property,plant,equipment --0--280--0--0
Other non- operating income (expenses) 90.94%-98.75K-8,709.51%-1.09M102.21%12.67K---573.42K
Income before tax -32.04%-4.13M-52.53%-3.13M-6.01%-2.05M-1.94M
Income tax -60.18%6531.64K00
Net income -31.99%-4.13M-52.61%-3.13M-6.01%-2.05M-1.94M
Net income continuous Operations -31.99%-4.13M-52.61%-3.13M-6.01%-2.05M---1.94M
Minority interest income -12.76%-2743.95%-243-36.02%-253-186
Net income attributable to the parent company -31.99%-4.13M-52.62%-3.13M-6.00%-2.05M-1.94M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -31.99%-4.13M-52.62%-3.13M-6.00%-2.05M-1.94M
Basic earnings per share -36.26%-0.39-52.62%-0.2862-6.00%-0.1875-0.1769
Diluted earnings per share -36.26%-0.39-52.62%-0.2862-6.00%-0.1875-0.1769
Dividend per share
Currency Unit SGDSGDSGDSGD
Audit Opinions Unqualified OpinionUnqualified Opinion----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg